Pitt Study Testing COVID-19 Vaccines in Autoimmune Diseases

Pitt Study Testing COVID-19 Vaccines in Autoimmune Diseases

305951

Pitt Study Testing COVID-19 Vaccines in Autoimmune Diseases

A new study being conducted at the University of Pittsburgh is testing the safety and effectiveness of COVID-19 vaccines in people with scleroderma and other autoimmune diseases. The CoVER study seeks to enroll adults, 18 or older, who have rheumatoid arthritis, Sjogren’s syndrome, myositis, or scleroderma, and who have already received a COVID-19 vaccine or are willing to do so. Anyone wanting to enroll or get more information can send an email to [email protected] While…

You must be logged in to read/download the full post.